Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Izildinha Maesta

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
BMJ Open|February 25, 2022
Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocolMariza Branco-Silva, Izildinha Maesta, Kevin Elias, et al.
Clinics (Sao Paulo, Brazil)|June 8, 2017
Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort studyFlavia Tarabini Castellani Asmar, Antonio Rodrigues Braga-Neto, Jorge de Rezende-Filho, et al.
Gynecologic Oncology|February 14, 2022
Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidismMarcos Montanha Ramos, Izildinha Maesta, Roberto Antonio de Araújo Costa, et al.
Gynecologic Oncology|December 11, 2025
Home-based treatment of low-risk gestational trophoblastic neoplasia with 8-day methotrexate/folinic acidIzildinha Maesta, Valdete Aparecida Ribeiro Silva, Roberto Antonio Araújo Costa, et al.
Plos One|December 1, 2022
Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasiaAntonio Braga, Ana Clara Canelas, Berenice Torres, et al.
Gynecologic Oncology|May 14, 2020
Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort studyFernanda Freitas, Antonio Braga, Mauricio Viggiano, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMJ Open|February 25, 2022
Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocolMariza Branco-Silva, Izildinha Maesta, Kevin Elias, et al.
Clinics (Sao Paulo, Brazil)|June 8, 2017
Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort studyFlavia Tarabini Castellani Asmar, Antonio Rodrigues Braga-Neto, Jorge de Rezende-Filho, et al.
Gynecologic Oncology|February 14, 2022
Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidismMarcos Montanha Ramos, Izildinha Maesta, Roberto Antonio de Araújo Costa, et al.
Gynecologic Oncology|December 11, 2025
Home-based treatment of low-risk gestational trophoblastic neoplasia with 8-day methotrexate/folinic acidIzildinha Maesta, Valdete Aparecida Ribeiro Silva, Roberto Antonio Araújo Costa, et al.
Plos One|December 1, 2022
Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasiaAntonio Braga, Ana Clara Canelas, Berenice Torres, et al.
Gynecologic Oncology|May 14, 2020
Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort studyFernanda Freitas, Antonio Braga, Mauricio Viggiano, et al.
Pageof 1